Team:MIT/testhomepage

From 2014.igem.org

(Difference between revisions)
Line 1: Line 1:
{{MIT-header}}
{{MIT-header}}
-
 
<html>
<html>
 +
<head>
 +
</head>
 +
<body style="font-family:Verdana, Geneva, sans-serif;">
 +
<table style="background-color:transparent; width:95%" align="center">
-
<!--main content -->
+
<tr> <td> <p> </p> </td> </tr>
-
<table style="width:100%" align="center">
+
 +
<tr>
 +
<td> <h3 style="color:black"> Alzheimer's disease affects the lives of millions. </h3> </td>
 +
</tr>
 +
<tr> <td> <p> </p> </td> </tr>
-
 
+
<tr>
-
<!--motivation box -->
+
<td>
-
<p> </p>
+
-
<h3 style="color:black">Alzheimer's disease affects the lives of millions.</h3>
+
-
<br> </br>
+
-
 
+
-
 
+
<table style="background-color:transparent; outline: solid black medium; width:60%" align="center">
<table style="background-color:transparent; outline: solid black medium; width:60%" align="center">
<tr>
<tr>
-
<td> [[File:MIT_2014_IconPlaceHolder.png|200px|center]] </td>
+
<td align="center"> <img src="https://static.igem.org/mediawiki/2014/5/55/MIT_2014_IconPlaceHolder.png" width="90%"> </img> </td>
-
<td> [[File:MIT_2014_IconPlaceHolder.png|200px|center]] </td>
+
<td align="center"> <img src="https://static.igem.org/mediawiki/2014/5/55/MIT_2014_IconPlaceHolder.png" width="90%"> </img> </td>
-
<td> [[File:MIT_2014_IconPlaceHolder.png|200px|center]] </td>
+
<td align="center"> <img src="https://static.igem.org/mediawiki/2014/5/55/MIT_2014_IconPlaceHolder.png" width="90%"> </img> </td>
</tr>
</tr>
<tr>
<tr>
Line 28: Line 29:
</tr>
</tr>
</table>
</table>
-
 
-
<br> </br>
 
-
<p> Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by memory loss, behavioral problems…  There is currently no cure for this disease, and existing diagnosis methods leave much to be desired.  MIT iGEM 2014 has set out to change this.  By detecting molecular biomarkers for AD, such as miRNAs and neurotoxic beta-amyloid plaques, and by regulating the production of beta-amyloid plaques, MIT iGEM hopes to create a dynamic solution for patients with Alzheimer’s disease.  Looking ahead, … delivery.
 
-
</p>
 
-
 
</td>
</td>
</tr>
</tr>
-
<tr> <td colspan="3"  height="5px"> </td></tr>
+
<tr> <td> <h3> </h3> </td> </tr>
-
<!-- end motivation box -->
+
-
 
+
-
<tr>  
+
 +
<tr>
 +
<td> <p> Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by memory loss, behavioral problems…  There is currently no cure for this disease, and existing diagnosis methods leave much to be desired.  MIT iGEM 2014 has set out to change this.  By detecting molecular biomarkers for AD, such as miRNAs and neurotoxic beta-amyloid plaques, and by regulating the production of beta-amyloid plaques, MIT iGEM hopes to create a dynamic solution for patients with Alzheimer’s disease.  Looking ahead, … delivery.
 +
</p> </td>
</tr>
</tr>
-
 
 +
<tr> <td> <h3> </h3> </td> </tr>
-
 
+
</table>
-
 
+
</body>
-
</td>
+
-
 
+
-
<tr> <td colspan="3"  height="15px"> </td></tr>
+
-
<tr><td bgColor="#e7e7e7" colspan="3" height="1px"> </tr>
+
-
<tr> <td colspan="3"  height="5px"> </td></tr>
+
-
 
+
-
<!--content-->
+

Revision as of 03:49, 5 October 2014

 


Image Map
Home Our Project Lab Work Outreach About Us Medals

Alzheimer's disease affects the lives of millions.

Neurodegenerative disease

6th leading cause of death

No cure

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by memory loss, behavioral problems… There is currently no cure for this disease, and existing diagnosis methods leave much to be desired. MIT iGEM 2014 has set out to change this. By detecting molecular biomarkers for AD, such as miRNAs and neurotoxic beta-amyloid plaques, and by regulating the production of beta-amyloid plaques, MIT iGEM hopes to create a dynamic solution for patients with Alzheimer’s disease. Looking ahead, … delivery.

Retrieved from "http://2014.igem.org/Team:MIT/testhomepage"